Author

Ivan R. Batlle

Observed names: Batlle, Ivan R., I Batlle, IVAN BATLLE, IVAN R. BATLLE, Ivan Batlle

Observed institution: Retina Associates

OpenAlex ID: A5026589146

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

2024 · David M Brown, David S Boyer, et al. · The Lancet · 159

Postoperative Hemorrhagic Occlusive Retinal Vasculitis

2015 · Andre J. Witkin, Anjali R. Shah, et al. · Ophthalmology · 147

Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time

2022 · Dennis M. Marcus, Paolo S. Silva, et al. · JAMA Ophthalmology · 88

Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time

2022 · Paolo S. Silva, Dennis M. Marcus, et al. · JAMA Ophthalmology · 87

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy

2023 · Raj K. Maturi, Adam R. Glassman, et al. · JAMA · 73

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

2018 · Lee M. Jampol, Adam R. Glassman, et al. · Ophthalmology · 43

Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema

2023 · David W. Hutton, Adam R. Glassman, et al. · JAMA Ophthalmology · 30

Ischemic and Hemorrhagic Retinal Vasculitis Associated With West Nile Virus Infection

2006 · SEEMA GARG, LEE M. JAMPOL, et al. · Retina · 26

Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion

2021 · Ahmad A. Aref, Ingrid U. Scott, et al. · JAMA Ophthalmology · 14

Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial

2023 · Steven M. Kymes, Neal L. Oden, et al. · JAMA Ophthalmology · 10

Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion

2022 · Ingrid U. Scott, Neal L. Oden, et al. · JAMA Ophthalmology · 6

Topical vitamin A ointment increases healing of cataract incisions.

1987 · P R Kastl, W N Rosenthal, et al. · PubMed · 6

Periocular Triamcinolone Acetonide as Treatment for Macular Edema Secondary to Branch Vein Occlusion Associated With Retinal Arteriovenous Malformation

2006 · THOMAS FEDERICI, IVAN BATLLE · Retina · 3

Ultra-Widefield Fluorescein Angiographic Quantitative Leakage Parameters and Clinical Outcomes in Nonproliferative Diabetic Retinopathy

2026 · Justis P. Ehlers, Kristin Josic, et al. · JAMA Ophthalmology · 2

Familial Exudative Vitreoretinopathy With Nasal Retinal Involvement: a Rare Presentation

2023 · Amelia Cooper, Henry Stevens, et al. · Retinal Cases & Brief Reports · 1

Diabetic Retinopathy Severity on Ultra-Widefield Fluorescein Angiography versus Color Photography and Association with Risk of Disease Worsening

2026 · Paolo S. Silva, Danni Liu, et al. · Ophthalmology Science

Hemorrhagic Occlusive Retinal Vasculitis after Cataract Extraction: A Vancomycin-Associated Reaction?

2015 · Michelle M. Kron-Gray, André J. Witkin, et al. · Investigative Ophthalmology & Visual Science

Works count: 18

Citation count: 689

H-index: 10

I10-index: 10